Found: 10
Select item for more details and to access through your institution.
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial).
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 12, p. 2691, doi. 10.1007/s40121-023-00882-2
- By:
- Publication type:
- Article
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection.
- Published in:
- Virus Evolution, 2021, v. 7, n. 2, p. 1, doi. 10.1093/ve/veab057
- By:
- Publication type:
- Article
Muscle-derived stem/progenitor cell dysfunction in Zmpste24-deficient progeroid mice limits muscle regeneration.
- Published in:
- Stem Cell Research & Therapy, 2013, v. 4, n. 2, p. 1, doi. 10.1186/scrt183
- By:
- Publication type:
- Article
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40057-8
- By:
- Publication type:
- Article
Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064923
- By:
- Publication type:
- Article
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1062067
- By:
- Publication type:
- Article
Factors influencing estimates of HIV-1 infection timing using BEAST.
- Published in:
- PLoS Computational Biology, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.pcbi.1008537
- By:
- Publication type:
- Article
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 8, p. 1055, doi. 10.1093/infdis/jiad210
- By:
- Publication type:
- Article
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.ppat.1008179
- By:
- Publication type:
- Article